CDK1 and head and neck squamous cell carcinoma: Finally, we validated the increased expression of the most relevant core gene, CDK1, in various HNSCC cell lines and demonstrated that menadione, the top predicted drug, could inhibit HNSCC cell proliferation and reverse CDK1 expression.